99 related articles for article (PubMed ID: 12722190)
1. [Changes in bacterial infectious diseases].
Hayashi H
Nihon Rinsho; 2003 Feb; 61 Suppl 2():41-52. PubMed ID: 12722190
[No Abstract] [Full Text] [Related]
2. [Strength in numbers: illness-causing biofilms].
Zijnge V; Abbas F; Degener JE
Ned Tijdschr Tandheelkd; 2008 Jan; 115(1):5-12. PubMed ID: 18265731
[TBL] [Abstract][Full Text] [Related]
3. The bacteria fight back.
Taubes G
Science; 2008 Jul; 321(5887):356-61. PubMed ID: 18635788
[No Abstract] [Full Text] [Related]
4. Prevalence of bacterial pathogens and their anti-microbial resistance in Tilapia and their pond water in Trinidad.
Newaj-Fyzul A; Mutani A; Ramsubhag A; Adesiyun A
Zoonoses Public Health; 2008 May; 55(4):206-13. PubMed ID: 18387142
[TBL] [Abstract][Full Text] [Related]
5. Surviving innate immunity.
Nizet V; Gallo RL
Trends Microbiol; 2002 Aug; 10(8):358-9. PubMed ID: 12160630
[No Abstract] [Full Text] [Related]
6. [Outline of the mechanism by which pathogenic microorganisms induce infectious diseases].
Kamiya S
Nihon Rinsho; 2007 Feb; 65 Suppl 2 Pt. 1():47-52. PubMed ID: 17455590
[No Abstract] [Full Text] [Related]
7. When medicines fail: recommendations for curbing antibiotic resistance.
Nugent R; Okeke IN
J Infect Dev Ctries; 2010 Jun; 4(6):355-6. PubMed ID: 20601785
[No Abstract] [Full Text] [Related]
8. [Ionizing radiations and the antimicrobial resistance of the body in warm-blooded animals].
Rudenko AV; Kruglikov VT
Mikrobiol Z; 1995; 57(1):102-10. PubMed ID: 7728272
[TBL] [Abstract][Full Text] [Related]
9. Pathogenic bacteria: how to get them back into the line of fire?
Keck W; Hubschwerlen C
Curr Opin Investig Drugs; 2005 Feb; 6(2):139-40. PubMed ID: 15751735
[No Abstract] [Full Text] [Related]
10. The challenge of treating biofilm-associated bacterial infections.
del Pozo JL; Patel R
Clin Pharmacol Ther; 2007 Aug; 82(2):204-9. PubMed ID: 17538551
[TBL] [Abstract][Full Text] [Related]
11. Bacterial adhesion--a source of alternate antibiotic targets.
Cusumano CK; Hultgren SJ
IDrugs; 2009 Nov; 12(11):699-705. PubMed ID: 19844856
[TBL] [Abstract][Full Text] [Related]
12. Letter in response to the Infectious Diseases Society of America's 10 x '20 Initiative.
Burgess DS; Slain D; Mohr J; Wong-Beringer A; Destache C; Suda K
Clin Infect Dis; 2010 Sep; 51(6):753; author reply 754-5. PubMed ID: 20731568
[No Abstract] [Full Text] [Related]
13. Antibacterial activity of carbapenems against clinically isolated respiratory bacterial pathogens in Japan between 2003 and 2004.
Watanabe A; Tokue Y; Kikuchi T; Gomi K; Aoki S; Satoh T; Fujimura S
Int J Antimicrob Agents; 2005 Nov; 26(5):420-3. PubMed ID: 16216468
[No Abstract] [Full Text] [Related]
14. Biomedicine. Hamiltonian medicine: why the social lives of pathogens matter.
Foster KR
Science; 2005 May; 308(5726):1269-70. PubMed ID: 15919984
[No Abstract] [Full Text] [Related]
15. [Viable non-culturable bacteria].
Năşcuţiu AM
Bacteriol Virusol Parazitol Epidemiol; 2010; 55(1):11-8. PubMed ID: 21038700
[TBL] [Abstract][Full Text] [Related]
16. Reducing antimicrobial resistance: a bold call to action.
Tambyah PA; Tan BH
Singapore Med J; 2008 Oct; 49(10):746-8. PubMed ID: 18946604
[No Abstract] [Full Text] [Related]
17. Plants as models for the study of human pathogenesis.
Guttman DS
Biotechnol Adv; 2004 May; 22(5):363-82. PubMed ID: 15063457
[TBL] [Abstract][Full Text] [Related]
18. Bacteria and phagocytes: mortal enemies.
Nizet V
J Innate Immun; 2010; 2(6):505-7. PubMed ID: 20829606
[No Abstract] [Full Text] [Related]
19. Antibiotics with an attitude: are they working?
Berlin B
N J Med; 1996 Nov; 93(11):25-31. PubMed ID: 8961743
[No Abstract] [Full Text] [Related]
20. [Management of antimicrobial resistance using information technology].
Aoki Y; Takayanagi M; Nagasawa Z; Mihara Y; Fukuoka M
Nihon Rinsho; 2007 Feb; 65 Suppl 2 Pt. 1():534-7. PubMed ID: 17455676
[No Abstract] [Full Text] [Related]
[Next] [New Search]